Resistance, resistant (to)

  • Resistance, resistant (to)
    • activated protein C - D68.51 Activated protein C resistance
    • complicating pregnancy - O26.89 Other specified pregnancy related conditions
    • insulin - E88.81 Metabolic syndrome
    • organism (s)
      • to
        • drug - Z16.30 Resistance to unspecified antimicrobial drugs
          • aminoglycosides - Z16.29 Resistance to other single specified antibiotic
          • amoxicillin - Z16.11 Resistance to penicillins
          • ampicillin - Z16.11 Resistance to penicillins
          • antibiotic (s) - Z16.20 Resistance to unspecified antibiotic
            • multiple - Z16.24 Resistance to multiple antibiotics
            • specified NEC - Z16.29 Resistance to other single specified antibiotic
          • antifungal - Z16.32 Resistance to antifungal drug(s)
          • antimicrobial (single) - Z16.30 Resistance to unspecified antimicrobial drugs
            • multiple - Z16.35 Resistance to multiple antimicrobial drugs
            • specified NEC - Z16.39 Resistance to other specified antimicrobial drug
          • antimycobacterial (single) - Z16.341 Resistance to single antimycobacterial drug
            • multiple - Z16.342 Resistance to multiple antimycobacterial drugs
          • antiparasitic - Z16.31 Resistance to antiparasitic drug(s)
          • antiviral - Z16.33 Resistance to antiviral drug(s)
          • beta lactam antibiotics - Z16.10 Resistance to unspecified beta lactam antibiotics
            • specified NEC - Z16.19 Resistance to other specified beta lactam antibiotics
          • cephalosporins - Z16.19 Resistance to other specified beta lactam antibiotics
          • extended beta lactamase (ESBL) - Z16.12 Extended spectrum beta lactamase (ESBL) resistance
          • fluoroquinolones - Z16.23 Resistance to quinolones and fluoroquinolones
          • macrolides - Z16.29 Resistance to other single specified antibiotic
          • methicillin - See: MRSA;
          • multiple drugs (MDRO)
            • antibiotics - Z16.24 Resistance to multiple antibiotics
            • antimicrobial - Z16.35 Resistance to multiple antimicrobial drugs
            • antimycobacterials - Z16.342 Resistance to multiple antimycobacterial drugs
          • penicillins - Z16.11 Resistance to penicillins
          • quinolones - Z16.23 Resistance to quinolones and fluoroquinolones
          • sulfonamides - Z16.29 Resistance to other single specified antibiotic
          • tetracyclines - Z16.29 Resistance to other single specified antibiotic
          • tuberculostatics (single) - Z16.341 Resistance to single antimycobacterial drug
            • multiple - Z16.342 Resistance to multiple antimycobacterial drugs
          • vancomycin - Z16.21 Resistance to vancomycin
    • thyroid hormone - E07.89 Other specified disorders of thyroid

Footnotes

Aminoglycosides: Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.

Amoxicillin: A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.

Ampicillin: Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.

Cephalosporins: A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.

Fluoroquinolones: A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.

Insulin: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).

Macrolides: A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.

Methicillin: One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.

Penicillins: A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)

Quinolones: A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.

Sulfonamides: A group of compounds that contain the structure SO2NH2.

Tetracyclines: Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)

Vancomycin: Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.

Previous Term
Residual
Next Term
Resorption